These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2007-003483-22 a double blind randomized study on the effectiveness of cyclopentolate 1% and cyclopentolate 1% with tropicamide 1% in dark irided hypermetropic children not-yet-due
Completed, but no date 2010-021410-34 A double blind randomized study on the efficacy of cyclopentolate 1% and cyclopentolate 1% with tropicamide 1% in children bad-data
No trial status on register 2012-001149-42 Cyclopentolate induced EEG changes in children Cyclopentolaat geinduceerde EEG veranderingen bij kinderen bad-data
Ongoing 2012-005387-10 Effect of Roux-en-Y gstric bypass surgery in morbidly obese patients on Pharmacokinetics of (Acetyl)salicylic acid and Omeprazole. not-yet-due
Reported results 2015-000180-13 The value of a High-Volume Image-Guided Injections (HVIGI) in chronic midportion Achilles tendinopathy: a double-blind, placebo-controlled, randomised clinical trial De waarde van Hoog-Volume Inje... 2019-07-09 due-trials
Not reported Terminated 2015-001563-39 Dexamethasone (DXM) therapy in symptomatic patients with chronic subdural hematoma (DECSA– Trial). Effect of initial corticosteroid therapy versus primary surgery on clinical outcome. 2021-02-01 due-trials
Ongoing 2019-003933-40 Prediction of Flucloxacillin Absorption and %time/MIC using the Flucloxacillin absorption test Voorspelbaarheid van de absorptie van flucloxacilline en %tijd/MIC van de flucloxacilline absorptietes... not-yet-due
Ongoing 2020-005731-67 Complement Inhibition: Attacking the Overshooting Inflammation @fter Subarachnoid Hemorrhage - A phase II trial on the safety and efficacy of C1 esterase inhibitor for the acute management of subarach... not-yet-due
Ongoing 2021-002162-40 IBIS: A single-centre, phase II study to evaluate the safety, tolerability and pharmacokinetics of 2-IminoBiotin in acute Ischemic Stroke due to large vessel occlusion not-yet-due